Difference between revisions of "Duvelisib (Copiktra)"
Jump to navigation
Jump to search
m |
m |
||
| Line 3: | Line 3: | ||
==Preliminary data== | ==Preliminary data== | ||
| + | ===[[Chronic lymphocytic leukemia (CLL) and Small lymphocytic lymphoma (SLL)|Chronic lymphocytic leukemia]]=== | ||
# '''Abstract:''' Manish Patel, Brad S. Kahl, Steven M. Horwitz, Francine M. Foss, Yasuhiro Oki, Pierluigi Porcu, Jennifer Sweeney, Kerstin Allen, Kerrie Faia, Patricia Harris, Joi Dunbar, Howard M. Stern, Patrick Kelly, Susan O'Brien. Preliminary Safety and Efficacy Of IPI-145, a Potent Inhibitor Of Phosphoinositide-3-Kinase-δ,γ, In Patients With Chronic Lymphocytic Leukemia. Blood Nov 2013,122(21)677 [http://bloodjournal.hematologylibrary.org/content/122/21/677 link to original abstract] | # '''Abstract:''' Manish Patel, Brad S. Kahl, Steven M. Horwitz, Francine M. Foss, Yasuhiro Oki, Pierluigi Porcu, Jennifer Sweeney, Kerstin Allen, Kerrie Faia, Patricia Harris, Joi Dunbar, Howard M. Stern, Patrick Kelly, Susan O'Brien. Preliminary Safety and Efficacy Of IPI-145, a Potent Inhibitor Of Phosphoinositide-3-Kinase-δ,γ, In Patients With Chronic Lymphocytic Leukemia. Blood Nov 2013,122(21)677 [http://bloodjournal.hematologylibrary.org/content/122/21/677 link to original abstract] | ||
| Line 10: | Line 11: | ||
[[Category:Kinase inhibitors]] | [[Category:Kinase inhibitors]] | ||
[[Category:PI3K inhibitors]] | [[Category:PI3K inhibitors]] | ||
| + | |||
| + | [[Category:Chronic lymphocytic leukemia (CLL) and Small lymphocytic lymphoma (SLL) medications]] | ||
[[Category:Investigational]] | [[Category:Investigational]] | ||
Revision as of 03:31, 26 November 2014
Mechanism of action
PI3K-δ,γ inhibitor
Preliminary data
Chronic lymphocytic leukemia
- Abstract: Manish Patel, Brad S. Kahl, Steven M. Horwitz, Francine M. Foss, Yasuhiro Oki, Pierluigi Porcu, Jennifer Sweeney, Kerstin Allen, Kerrie Faia, Patricia Harris, Joi Dunbar, Howard M. Stern, Patrick Kelly, Susan O'Brien. Preliminary Safety and Efficacy Of IPI-145, a Potent Inhibitor Of Phosphoinositide-3-Kinase-δ,γ, In Patients With Chronic Lymphocytic Leukemia. Blood Nov 2013,122(21)677 link to original abstract